Due to global asthma prevalence, asthma product sales are rising. City living, pollution, and lifestyle changes are causing more lung diseases. This increases the requirement for asthma control equipment.
New innovations are transforming the asthma device industry, notably breathing equipment. Smart inhalers with sensors and connections are becoming increasingly prevalent. These provide patients real-time feedback on their inhalation and medication compliance. Doctors can better manage illnesses and treat patients using this technology.
Digital asthma management alternatives are growing in popularity. Personalized treatment plans, remote monitoring, and teleconsultations are being offered via mobile applications, EHRs, and telemedicine platforms. This makes patients more engaged in and committed to therapy.
Kids' asthma care is getting more attention, and age-appropriate, easy-to-use asthma products are being developed. Youth asthma management is made simpler and more exciting with easy-to-use inhalers, colored spacers, and game-like mobile applications.
Biologics and targeted asthma therapies are popular. These devices-based therapies target asthma inflammatory mechanisms. This provides severe asthmatics more effective and tailored options.
Asthma devices are increasingly integrating environmental monitoring functions. These devices can monitor air quality, pollen, and other asthma triggers. These devices notify users about their environment to prevent asthma attacks.
Patient-centered and easy-to-use asthma products are growing in popularity. To help patients self-administer, inhalers and other devices are being designed with ergonomic design, easy-to-read dosage indicators, and auditory cues.
Partnerships between medicine firms, device producers, and healthcare personnel affect the asthma goods industry. Global agreements and alliances strive to simplify product development and distribution so more individuals can use better asthma control methods.
Portable nebulizers are popular since they're simple to use and effective for asthmatics. These portable devices provide asthmatics who require regular or emergency treatments greater freedom and flexibility.
Despite advancements, breathing equipment is still hard to obtain, particularly in low-income communities. Education, cost reduction, and worldwide partnerships strive to narrow these gaps and make asthma management measures more accessible.
Figure 1:- Global asthma devices market share, by region Â
Sources: WHO, annual reports, press release, white paper, and company presentation
Asthma Devices Market Segmentation
The global asthma devices market is segmented on the basis of type, technology, and end users.
On the basis of the type, the market is segmented into inhalers, nebulizers, and others. The inhalers segment is sub-segmented into metered-dose inhalers and dry powder inhalers. The metered-dose inhalers segment, by inhalers, is further categorized into standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, metered-dose inhalers with a spacer, and others. The nebulizers segment is sub-segmented into compressor nebulizers, ultrasonic nebulizers, mesh nebulizers, and others.
On the basis of technology, the asthma devices market is segmented into manually operated inhaler devices, digitally operated inhaler devices, and others.
On the basis of end users, the market is segmented into hospital, clinics, retail pharmacies, and others.
Asthma Devices Market Regional AnalysisÂ
Key players for Asthma Devices Market
GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (U.S.), 3M (U.S.), Aristopharma Ltd. (Asia Pacific), SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific), AstraZeneca (Europe), Baxter. (U.S.), Boehringer Ingelheim GmbH (Europe), Koninklijke Philips N.V. (Europe), and others.
Intended Audience
Research Methodology
Â
Sources: WHO, annual reports, press release, white paper, and company presentationÂ
Â
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)